Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 284 of 284 entries
Sorted by: Best Match Show Resources per page
Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort.

Travel medicine and infectious disease

Creutz I, Busche T, Layer F, Bednarz H, Kalinowski J, Niehaus K.
PMID: 34785377
Travel Med Infect Dis. 2021 Nov 13;45:102204. doi: 10.1016/j.tmaid.2021.102204. Epub 2021 Nov 13.

BACKGROUND: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) seem to be highly transmissible, often infect otherwise healthy humans and frequently occur in hospital outbreaks.METHODS: Refugees, living in accommodations in Germany were screened for nasal carriage of S. aureus. The isolates were...

Cite
Creutz I, Busche T, Layer F, et al. Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort. Travel Med Infect Dis. 2021;45:102204doi: 10.1016/j.tmaid.2021.102204.
Creutz, I., Busche, T., Layer, F., Bednarz, H., Kalinowski, J., & Niehaus, K. (2021). Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort. Travel medicine and infectious disease, 45102204. https://doi.org/10.1016/j.tmaid.2021.102204
Creutz, Ines, et al. "Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort." Travel medicine and infectious disease vol. 45 (2021): 102204. doi: https://doi.org/10.1016/j.tmaid.2021.102204
Creutz I, Busche T, Layer F, Bednarz H, Kalinowski J, Niehaus K. Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort. Travel Med Infect Dis. 2021 Nov 13;45:102204. doi: 10.1016/j.tmaid.2021.102204. Epub 2021 Nov 13. PMID: 34785377.
Copy Download .nbib Format: NLM
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations.

Clinical cancer research : an official journal of the American Association for Cancer Research

Adib E, Klonowska K, Giannikou K, Do KT, Pruitt-Thompson S, Bhushan K, Milstein MI, Hedglin J, Kargus KE, Sholl LM, Tsuji J, Hyman DM, Sisk A, Shapiro GI, Vargas HA, Harding JJ, Voss MH, Iyer G, Kwiatkowski DJ.
PMID: 33727259
Clin Cancer Res. 2021 Jul 15;27(14):3845-3853. doi: 10.1158/1078-0432.CCR-20-4548. Epub 2021 Mar 16.

PURPOSE: This was a multicenter, histology-agnostic, single-arm prospective phase II trial of therapeutic activity of everolimus, an oral mTORC1 inhibitor, in patients with advanced solid tumors that harbored PATIENTS AND METHODS: Patients with tumors with inactivating RESULTS: Between November...

Cite
Adib E, Klonowska K, Giannikou K, et al. Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations. Clin Cancer Res. 2021;27(14):3845-3853doi: 10.1158/1078-0432.CCR-20-4548.
Adib, E., Klonowska, K., Giannikou, K., Do, K. T., Pruitt-Thompson, S., Bhushan, K., Milstein, M. I., Hedglin, J., Kargus, K. E., Sholl, L. M., Tsuji, J., Hyman, D. M., Sisk, A., Shapiro, G. I., Vargas, H. A., Harding, J. J., Voss, M. H., Iyer, G., & Kwiatkowski, D. J. (2021). Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(14), 3845-3853. https://doi.org/10.1158/1078-0432.CCR-20-4548
Adib, Elio, et al. "Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,14 (2021): 3845-3853. doi: https://doi.org/10.1158/1078-0432.CCR-20-4548
Adib E, Klonowska K, Giannikou K, Do KT, Pruitt-Thompson S, Bhushan K, Milstein MI, Hedglin J, Kargus KE, Sholl LM, Tsuji J, Hyman DM, Sisk A, Shapiro GI, Vargas HA, Harding JJ, Voss MH, Iyer G, Kwiatkowski DJ. Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations. Clin Cancer Res. 2021 Jul 15;27(14):3845-3853. doi: 10.1158/1078-0432.CCR-20-4548. Epub 2021 Mar 16. PMID: 33727259; PMCID: PMC8282751.
Copy Download .nbib Format: NLM
Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes.

Diabetes research and clinical practice

Zmysłowska A, Jakiel P, Gadzalska K, Majos A, Płoszaj T, Ben-Skowronek I, Deja G, Glowinska-Olszewska B, Jarosz-Chobot P, Klonowska B, Kowalska I, Mlynarski W, Mysliwiec M, Nazim J, Noczynska A, Robak-Kontna K, Skala-Zamorowska E, Skowronska B, Szadkowska A, Szypowska A, Walczak M, Borowiec M.
PMID: 34826540
Diabetes Res Clin Pract. 2021 Nov 24;183:109154. doi: 10.1016/j.diabres.2021.109154. Epub 2021 Nov 24.

AIM: Monogenic diabetes (MD) represents 5-7% of antibody-negative diabetes cases and is a heterogeneous group of disorders.METHODS: We used targeted next-generation sequencing (NGS) on Illumina NextSeq 550 platform involving the SureSelect assay to perform genetic and clinical characteristics of...

Cite
Zmysłowska A, Jakiel P, Gadzalska K, et al. Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes. Diabetes Res Clin Pract. 2021;183:109154doi: 10.1016/j.diabres.2021.109154.
Zmysłowska, A., Jakiel, P., Gadzalska, K., Majos, A., Płoszaj, T., Ben-Skowronek, I., Deja, G., Glowinska-Olszewska, B., Jarosz-Chobot, P., Klonowska, B., Kowalska, I., Mlynarski, W., Mysliwiec, M., Nazim, J., Noczynska, A., Robak-Kontna, K., Skala-Zamorowska, E., Skowronska, B., Szadkowska, A., Szypowska, A., Walczak, M., & Borowiec, M. (2021). Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes. Diabetes research and clinical practice, 183109154. https://doi.org/10.1016/j.diabres.2021.109154
Zmysłowska, A, et al. "Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes." Diabetes research and clinical practice vol. 183 (2021): 109154. doi: https://doi.org/10.1016/j.diabres.2021.109154
Zmysłowska A, Jakiel P, Gadzalska K, Majos A, Płoszaj T, Ben-Skowronek I, Deja G, Glowinska-Olszewska B, Jarosz-Chobot P, Klonowska B, Kowalska I, Mlynarski W, Mysliwiec M, Nazim J, Noczynska A, Robak-Kontna K, Skala-Zamorowska E, Skowronska B, Szadkowska A, Szypowska A, Walczak M, Borowiec M. Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes. Diabetes Res Clin Pract. 2021 Nov 24;183:109154. doi: 10.1016/j.diabres.2021.109154. Epub 2021 Nov 24. PMID: 34826540.
Copy Download .nbib Format: NLM
A novel plant-fungal association reveals fundamental sRNA and gene expression reprogramming at the onset of symbiosis.

BMC biology

Šečić E, Zanini S, Wibberg D, Jelonek L, Busche T, Kalinowski J, Nasfi S, Thielmann J, Imani J, Steinbrenner J, Kogel KH.
PMID: 34429124
BMC Biol. 2021 Aug 24;19(1):171. doi: 10.1186/s12915-021-01104-2.

No abstract available.

Cite
Šečić E, Zanini S, Wibberg D, et al. A novel plant-fungal association reveals fundamental sRNA and gene expression reprogramming at the onset of symbiosis. BMC Biol. 2021;19(1):171doi: 10.1186/s12915-021-01104-2.
Šečić, E., Zanini, S., Wibberg, D., Jelonek, L., Busche, T., Kalinowski, J., Nasfi, S., Thielmann, J., Imani, J., Steinbrenner, J., & Kogel, K. H. (2021). A novel plant-fungal association reveals fundamental sRNA and gene expression reprogramming at the onset of symbiosis. BMC biology, 19(1), 171. https://doi.org/10.1186/s12915-021-01104-2
Šečić, Ena, et al. "A novel plant-fungal association reveals fundamental sRNA and gene expression reprogramming at the onset of symbiosis." BMC biology vol. 19,1 (2021): 171. doi: https://doi.org/10.1186/s12915-021-01104-2
Šečić E, Zanini S, Wibberg D, Jelonek L, Busche T, Kalinowski J, Nasfi S, Thielmann J, Imani J, Steinbrenner J, Kogel KH. A novel plant-fungal association reveals fundamental sRNA and gene expression reprogramming at the onset of symbiosis. BMC Biol. 2021 Aug 24;19(1):171. doi: 10.1186/s12915-021-01104-2. PMID: 34429124; PMCID: PMC8385953.
Copy Download .nbib Format: NLM
Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort.

Travel medicine and infectious disease

Creutz I, Busche T, Layer F, Bednarz H, Kalinowski J, Niehaus K.
PMID: 34785377
Travel Med Infect Dis. 2021 Nov 13;45:102204. doi: 10.1016/j.tmaid.2021.102204. Epub 2021 Nov 13.

BACKGROUND: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) seem to be highly transmissible, often infect otherwise healthy humans and frequently occur in hospital outbreaks.METHODS: Refugees, living in accommodations in Germany were screened for nasal carriage of S. aureus. The isolates were...

Cite
Creutz I, Busche T, Layer F, et al. Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort. Travel Med Infect Dis. 2021;45:102204doi: 10.1016/j.tmaid.2021.102204.
Creutz, I., Busche, T., Layer, F., Bednarz, H., Kalinowski, J., & Niehaus, K. (2021). Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort. Travel medicine and infectious disease, 45102204. https://doi.org/10.1016/j.tmaid.2021.102204
Creutz, Ines, et al. "Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort." Travel medicine and infectious disease vol. 45 (2021): 102204. doi: https://doi.org/10.1016/j.tmaid.2021.102204
Creutz I, Busche T, Layer F, Bednarz H, Kalinowski J, Niehaus K. Evaluation of virulence potential of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates from a German refugee cohort. Travel Med Infect Dis. 2021 Nov 13;45:102204. doi: 10.1016/j.tmaid.2021.102204. Epub 2021 Nov 13. PMID: 34785377.
Copy Download .nbib Format: NLM
Longitudinal, Quantitative, Multimodal MRI Evaluation of Patients With Intracerebral Hemorrhage Over the First Year.

Frontiers in neurology

Haque ME, Boren SB, Arevalo OD, Gupta R, George S, Parekh MA, Zhao X, Aronowski J, Savitz SI.
PMID: 34917017
Front Neurol. 2021 Nov 30;12:764718. doi: 10.3389/fneur.2021.764718. eCollection 2021.

In most patients with intracerebral hemorrhage (ICH), the hematoma and perihematomal area decrease over the subsequent months but patients continue to exhibit neurological impairments. In this serial imaging study, we characterized microstructural and neurophysiological changes in the ICH-affected brain...

Cite
Haque ME, Boren SB, Arevalo OD, et al. Longitudinal, Quantitative, Multimodal MRI Evaluation of Patients With Intracerebral Hemorrhage Over the First Year. Front Neurol. 2021;12:764718doi: 10.3389/fneur.2021.764718.
Haque, M. E., Boren, S. B., Arevalo, O. D., Gupta, R., George, S., Parekh, M. A., Zhao, X., Aronowski, J., & Savitz, S. I. (2021). Longitudinal, Quantitative, Multimodal MRI Evaluation of Patients With Intracerebral Hemorrhage Over the First Year. Frontiers in neurology, 12764718. https://doi.org/10.3389/fneur.2021.764718
Haque, Muhammad E, et al. "Longitudinal, Quantitative, Multimodal MRI Evaluation of Patients With Intracerebral Hemorrhage Over the First Year." Frontiers in neurology vol. 12 (2021): 764718. doi: https://doi.org/10.3389/fneur.2021.764718
Haque ME, Boren SB, Arevalo OD, Gupta R, George S, Parekh MA, Zhao X, Aronowski J, Savitz SI. Longitudinal, Quantitative, Multimodal MRI Evaluation of Patients With Intracerebral Hemorrhage Over the First Year. Front Neurol. 2021 Nov 30;12:764718. doi: 10.3389/fneur.2021.764718. eCollection 2021. PMID: 34917017; PMCID: PMC8670985.
Copy Download .nbib Format: NLM
Sézary Syndrome Shows Whole Genome Duplication as a Late Event in Tumor Evolution.

The Journal of investigative dermatology

Hain C, Stadler R, Kalinowski J.
PMID: 34808235
J Invest Dermatol. 2021 Nov 19; doi: 10.1016/j.jid.2021.11.009. Epub 2021 Nov 19.

No abstract available.

Cite
Hain C, Stadler R, Kalinowski J. Sézary Syndrome Shows Whole Genome Duplication as a Late Event in Tumor Evolution. J Invest Dermatol. 2021;doi: 10.1016/j.jid.2021.11.009.
Hain, C., Stadler, R., & Kalinowski, J. (2021). Sézary Syndrome Shows Whole Genome Duplication as a Late Event in Tumor Evolution. The Journal of investigative dermatology, . https://doi.org/10.1016/j.jid.2021.11.009
Hain, Carsten, et al. "Sézary Syndrome Shows Whole Genome Duplication as a Late Event in Tumor Evolution." The Journal of investigative dermatology vol. (2021). doi: https://doi.org/10.1016/j.jid.2021.11.009
Hain C, Stadler R, Kalinowski J. Sézary Syndrome Shows Whole Genome Duplication as a Late Event in Tumor Evolution. J Invest Dermatol. 2021 Nov 19; doi: 10.1016/j.jid.2021.11.009. Epub 2021 Nov 19. PMID: 34808235.
Copy Download .nbib Format: NLM
α.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Dienel A, Veettil RA, Matsumura K, Savarraj JPJ, Choi HA, Kumar T P, Aronowski J, Dash P, Blackburn SL, McBride DW.
PMID: 33970466
Neurotherapeutics. 2021 Jul;18(3):1891-1904. doi: 10.1007/s13311-021-01052-3. Epub 2021 May 10.

Aneurysmal subarachnoid hemorrhage (aSAH) causes a robust inflammatory response which leads worse brain injury and poor outcomes. We investigated if stimulation of nicotinic acetylcholine α

Cite
Dienel A, Veettil RA, Matsumura K, et al. α. Neurotherapeutics. 2021;18(3):1891-1904doi: 10.1007/s13311-021-01052-3.
Dienel, A., Veettil, R. A., Matsumura, K., Savarraj, J. P. J., Choi, H. A., Kumar T, P., Aronowski, J., Dash, P., Blackburn, S. L., & McBride, D. W. (2021). α. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 18(3), 1891-1904. https://doi.org/10.1007/s13311-021-01052-3
Dienel, Ari, et al. "α." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics vol. 18,3 (2021): 1891-1904. doi: https://doi.org/10.1007/s13311-021-01052-3
Dienel A, Veettil RA, Matsumura K, Savarraj JPJ, Choi HA, Kumar T P, Aronowski J, Dash P, Blackburn SL, McBride DW. α. Neurotherapeutics. 2021 Jul;18(3):1891-1904. doi: 10.1007/s13311-021-01052-3. Epub 2021 May 10. PMID: 33970466; PMCID: PMC8609090.
Copy Download .nbib Format: NLM
Showing 277 to 284 of 284 entries